A historical, scientific and commercial perspective on the medicinal use of Pelargonium sidoides (Geraniaceae).
Study Design
- Tipo di studio
- Review
- Popolazione
- None
- Intervento
- A historical, scientific and commercial perspective on the medicinal use of Pelargonium sidoides (Geraniaceae). None
- Comparatore
- None
- Esito primario
- A historical, scientific and commercial perspective on the medicinal use of Pela
- Direzione dell'effetto
- Mixed
- Rischio di bias
- Unclear
Abstract
UNLABELLED: ETHNOPHARMACOLOGICAL CONTEXT: A detailed review of the ethnobotany and commercial history of Pelargonium sidoides is presented, together with a brief summary of pre-clinical and clinical scientific results that support the use of the plant in modern, evidence-based phytomedicines. The aim is to identify the main factors responsible for the success in product development. MATERIALS AND METHODS: The literature studied includes all modern scientific papers and also old documents and books that are no longer readily accessible. RESULTS: Available ethnobotanical information shows that several tuberous Pelargonium species (including Pelargonium sidoides) are important traditional medicines with a rich ethnobotanical history. A summary of the interesting history of the commercial development of Stevens' Cure or Umckaloabo in Europe is presented. Scientific evidence for the efficacy of the product, mainly as a treatment for acute bronchitis, is reviewed. These include numerous in vitro studies as well as 18 clinical studies. The botanical identity of the plant and its complex mixture of coumarins and other chemical constituents are summarised. CONCLUSIONS: The use of Pelargonium stems or tubers for a variety of ailments (including the complications of dysentery) is an important but hitherto under-estimated part of traditional medicine in southern Africa. Key elements in the successful development of Pelargonium sidoides from a profound traditional remedy to a highly successful phytomedicine include the choice of species, a favourable cost-benefit ratio, innovative marketing over many years, good scientific evidence of the botanical and chemical identity of the product and convincing proof of concept.
TL;DR
Key elements in the successful development of Pelargonium sidoides from a profound traditional remedy to a highly successful phytomedicine include the choice of species, a favourable cost-benefit ratio, innovative marketing over many years, good scientific evidence of the botanical and chemical identity of the product and convincing proof of concept.
Used In Evidence Reviews
Similar Papers
Phytomedicine : international journal of phytotherapy and phytopharmacology · 2011
Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses.
The Cochrane database of systematic reviews · 2013
Pelargonium sidoides extract for treating acute respiratory tract infections.
Antiviral research · 2012
EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo.
Phytomedicine : international journal of phytotherapy and phytopharmacology · 2003
Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial.
Phytomedicine : international journal of phytotherapy and phytopharmacology · 2008
Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis.
Explore (New York, N.Y.) · 2005